"REKOL-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID9511975279

KRS0000125489

Share capital330,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. SONATY 5 / LOK. U1, 02-744 WARSZAWA

Show on map

E-mail

[email protected]

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

"REKOL-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. SONATY 5 / LOK. U1, 02-744 WARSZAWA

Show on map

NIP

9511975279

REGON

008421793

KRS

0000125489

Legal form

limited liability company

Register Address

UL. SONATY 5 / LOK. U1, 02-744 WARSZAWA

Date of registration in KRS

2002-08-07

Date of commencement of economic activity

2002-08-07

Act signature

RDF/716994/25/470

Pkd codes

86.21.Z - General medical practice

47.1 - Non-specialized retail trade

47.73.Z - Retail sale of pharmaceutical products

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

47.9 - Retail sale via intermediaries

70.22.Z - Head office activities and management consultancy

73.1 - Advertising

86.10.Z - Hospital activities

86.90 - Other healthcare activities

Payer VAT status

exempted

Vat list bank account(s)

PL16 1020 1169 0000 8502 0011 2359

Company authorities

representation authorityMANAGEMENT

representation type

DWAJ CZŁONKOWIE ZARZĄDU LUB CZŁONEK ZARZĄDU I PROKURENT ŁĄCZNIE

MANAGEMENT

Katarzyna Anna Praśniewska Steggles

Chairman Of The Board, 59 years old

Anna Krystyna Korczak

V-vice President, 70 years old

shareholders

Katarzyna Anna Praśniewska Steggles

627 udziałów o łącznej wysokości 313.500 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale
Gross profit (loss)	-0,2	0,2	0,4	147,5
EBITDA	-0,1	0,3	0,6	111,3
Short time liabilities	1,9	1,8	1,6	-11,8
Other operating costs
Equity capital	-0,9	-0,8	-0,4	47,4
Operating profit (EBIT)	-0,2	0,2	0,5	124,9
Assets	1	1	1,1	16,8
Net profit (loss)	-0,2	0,1	0,4	228,1
Cash	0	0	0	-40,6
Net income from sale	8	9,5	11,1	16,5
Liabilities and provisions for liabilities	1,9	1,8	1,6	-11,8
Working assets	0,9	0,9	1	18,6
Other income costs
Depreciation	0,2	0,1	0,1	74,1
	%	%	%	p.p.
Profitability of capital	26	-14,5	-90,3	-75,8
Equity capital to total assets	-91,3	-80,4	-36,2	44,2
Gross profit margin	-2,9	1,9	3,9	2
EBITDA Margin	-0,6	3	5,5	2,5
	Days	Days	Days	Days
Short term commitment turnover cycle	86	68	52	-16

Current financial liquidity indicator	0.4729963541030884	0.49478310346603394	0.665788471698761	0,2
Net dept to EBITDA	-4.532391548156738	0.7171130180358887	0.23529332876205444	-0,5